[HTML][HTML] A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants

…, SR Duncan, SJ Forman, JA Zaia… - … England Journal of …, 1991 - Mass Medical Soc
Background. Cytomegalovirus (CMV)-associated interstitial pneumonia is a major cause of
death after allogeneic bone marrow transplantation. We conducted a controlled trial of …

RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

…, D Hsu, SJ Forman, JJ Rossi, JA Zaia - Science translational …, 2010 - science.org
AIDS patients who develop lymphoma are often treated with transplanted hematopoietic
progenitor cells. As a first step in developing a hematopoietic cell–based gene therapy treatment…

Ribozymes as potential anti-HIV-1 therapeutic agents

N Sarver, EM Cantin, PS Chang, JA Zaia, PA Ladne… - Science, 1990 - science.org
Certain RNA molecules, called ribozymes, possess enzymatic, self-cleaving activity. The
cleavage reaction is catalytic and no energy source is required. Ribozymes of the "hammerhead…

[HTML][HTML] The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell …

JA Zaia, JY Sun, GM Gallez-Hawkins, L Thao… - Biology of Blood and …, 2009 - Elsevier
It has been shown that activating killer Ig-like receptor (aKIR) genes are important for control
of cytomegalovirus (CMV) reactivation after hematopoietic cell transplantation (HCT). To …

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

…, R Nakamura, SJ Forman, JA Zaia… - Blood, The Journal …, 2009 - ashpublications.org
Reconstitution of cytomegalovirus (CMV)–specific CD8 + T cells is essential to the control of
CMV infection in CMV-positive recipients (R + ) after allogeneic hematopoietic stem cell …

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes

…, B Tanamachi, CR Li, JA Zaia… - Journal of medical …, 1994 - Wiley Online Library
Primary Cytomegalovirus (CMV) infection and reactivation of persistent CMV are associated
with significant morbidity and mortality in immuno‐compromised individuals. Although …

Acyclovir halts progression of herpes zoster in immunocompromised patients

…, JD Meyers, JC Wade, JA Zaia… - … England Journal of …, 1983 - Mass Medical Soc
We conducted a placebo-controlled, double-blind study of acyclovir therapy for acute herpes
zoster in immunocompromised patients. Of the 94 patients enrolled in the study, 52 had …

Airborne transmission of chickenpox in a hospital

JM Leclair, JA Zaia, MJ Levin… - … England Journal of …, 1980 - Mass Medical Soc
The occurrence of chickenpox in pediatric hospitals disrupts routine care of immunologically
normal patients and is potentially life-threatening to immunosuppressed patients. …

Direct detection of HIV-1 RNA from AIDS and ARC patient samples

GJ MURAKAWA, JA ZAIA, PA SPALLONE… - Dna, 1988 - liebertpub.com
Human immunodeficiency virus (HIV), formerly termed human T-lymphotropic virus (HTLVIII/LAV),
is the etiological agent of acquired immune deficiency syndrome (AIDS). Direct …

Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases

…, PD Gregory, Q Liu, MC Holmes, PM Cannon, JA Zaia… - Molecular Therapy, 2013 - cell.com
The HIV-1 coreceptor CCR5 is a validated target for HIV/AIDS therapy. The apparent elimination
of HIV-1 in a patient treated with an allogeneic stem cell transplant homozygous for a …